EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
3,584,885
Share change
+3,584,885
Total reported value
$55,529,000
Price per share
$15.49
Number of holders
27
Value change
+$55,529,019
Number of buys
27

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q3 2019

As of 30 Sep 2019, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,584,885 shares. The largest 10 holders included RTW INVESTMENTS, LP, PRICE T ROWE ASSOCIATES INC /MD/, VICTORY CAPITAL MANAGEMENT INC, WASATCH ADVISORS INC, FARALLON CAPITAL MANAGEMENT LLC, Broadfin Capital, LLC, NEXT CENTURY GROWTH INVESTORS LLC, CALAMOS ADVISORS LLC, Monashee Investment Management LLC, and PERKINS CAPITAL MANAGEMENT INC. This page lists 27 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.